Heterocyclic compounds as factor ixa inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 231/18 (2006.01) A61K 31/415 (2006.01) A61K 31/4152 (2006.01) A61K 31/4155 (2006.01) A61K 31/416 (2006.01) A61P 7/02 (2006.01) C07D 401/04 (2006.01) C07D 401/14 (2006.01) C07D 403/04 (2006.01) C07D 403/14 (2006.01) C07D 413/04 (2006.01) C07D 413/14 (2006.01) C07D 487/04 (2006.01)

Patent

CA 2724430

The present invention relates to novel heterocyclic compounds of Formulae I-III; as disclosed herein or a pharmaceutically acceptable salt, solvate, ester, prodrug or stereoisomer thereof. Also disclosed are pharmaceutical compositions comprising said compounds, and methods for using said compounds for treating or preventing a thromboembolic disorder. Image

La présente invention concerne de nouveaux composés hétérocycliques répondant aux formules I à III : Formule I ; formule II ; Formule III telles que décrites dans le présent document ou un sel, solvate, ester, promédicament ou stéréoisomère pharmaceutiquement acceptable de ceux-ci. La présente invention concerne en outre des compositions pharmaceutiques comprenant lesdits composés, et des procédés dutilisation desdits composés pour le traitement ou la prévention dun trouble thromboembolique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Heterocyclic compounds as factor ixa inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic compounds as factor ixa inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds as factor ixa inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1452347

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.